Skip to content
Dark
Search
Sign In
Subscribe
Home
About
Research Notes
Slide Decks
SPAC IPOs
Spinoffs
Healthcare
—
biotech
GlobeImmune offers little promise for IPO investors.
,
and
Kris Tuttle
September 25, 2012
. 5:44 PM
1 min read
Share on Twitter
Share on Facebook
Share on Pinterest
Share on LinkedIn
Share on WhatsApp
Share via Email
This post is for paying subscribers only
Subscribe
Already have an account?
Sign In
Related
SPAC Deck
enGene via Forbion European (FRBN) deck
,
and
Debarshi Ghosh
May 24, 2023
Healthcare
Some Healthy SPACs
,
and
Kris Tuttle
May 8, 2023
Consumer
Kenvue: An IPO for the moment.
,
and
Kris Tuttle
May 4, 2023
SPAC Deck
Avertix (AVRT) via BioPlus Acq (BIOS) deck
,
and
Debarshi Ghosh
May 3, 2023
Latest
Consumer
First Bite of CAVA
,
and
Kris Tuttle
May 30, 2023
SPAC Deck
MoneyHero Group (MNY) via Bridgetown (BTWN) deck
,
and
Debarshi Ghosh
May 26, 2023
IPO deck
Caliber (CWD) IPO deck
,
and
Debarshi Ghosh
May 24, 2023
IPO deck
ALE Group (ALEH) IPO deck
,
and
Debarshi Ghosh
May 24, 2023
